← Leaderboards
Sven De Vos
University Of California Los Angeles
$1,138,671
Attributed
$1,138,671
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $164.3K · FY2005–13$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,138,671 · 4
By mechanism
P30$753,962 · 1
K23$364,650 · 1
M01$20,059 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ren Sun$20,189,518
- Otoniel Martinez-Maza$22,455,072
- Maxime Cannesson$8,107,727
- Alex Bui$24,761,003
- Heather Christofk$9,647,151
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingSafetyClinical ResearchClinical TrialsDesignEmployeeEnrollmentDoctor Of PhilosophyDropsAffectAmendmentCase StudyBaseEducational ActivitiesAdverse EventClinical Data Update SystemAnticancer ResearchClinical Trials Data Monitoring CommitteesBusinessesConsensusCommunicationComprehensive Cancer CenterAuthorityDatabase Structure
Grant awards (10)
Data and Safety Monitoring Board$161,609
P30 · FY2013 · CA · contact PI
Data and Safety Monitoring Board$139,509
P30 · FY2012 · CA · contact PI
Data and Safety Monitoring Board$132,900
P30 · FY2011 · CA · contact PI
Data and Safety Monitoring Board$164,323
P30 · FY2010 · CA · contact PI
Data and Safety Monitoring Board$155,621
P30 · FY2009 · CA · contact PI
A PILOT STUDY OF INDUCING AND TARGETING EBV-TK IN EBV-POSITIVE LYMPHOMAS BY C$13,190
M01 · FY2008 · RR · contact PI
A PILOT STUDY OF INDUCING AND TARGETING EBV-TK IN EBV-POSITIVE LYMPHOMAS BY C$6,869
M01 · FY2007 · RR · contact PI
Inducing and targeting of EBV lytic antigens in lymphoma$120,690
K23 · FY2006 · RR · contact PI
Inducing and targeting of EBV lytic antigens in lymphoma$120,690
K23 · FY2005 · RR
Inducing and targeting of EBV lytic antigens in lymphoma$123,270
K23 · FY2004 · RR